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Abstract
Background: The aim of this investigation was to study change in adults over a 20 year period in the prevalence
of respiratory symptoms and disorders and its association to year of birth, life style and sleep related variables.
Method: Adults 20–44 years of age, 6085 women and 5184 men, were randomly selected from seven centres in
Northern Europe and followed for 20 years. The number of participants in the first survey was 21,595 and 11,269
participated in all three surveys. The participants were divided into three birth cohorts: 1944–1955, 1956–1965 and
1966–1975.
Results: During the 20 year period the prevalence of wheeze decreased (− 2%) and the prevalence of asthma
(+ 4%) and allergic rhinitis (+ 5%) increased, whereas the prevalence of nocturnal respiratory symptoms was relatively
unchanged. The increase in allergic rhinitis was largest in those born 1966 to 1975 except in Estonia. There was large
decrease in smoking (− 20%), increase in obesity (+ 7%) and snoring (+ 6%) during the study period. Smoking, obesity,
snoring and nocturnal gastroesophageal reflux (nGER) were related to a higher risk of all symptoms. Obesity, snoring
and nGER were also independently related to asthma.
Conclusion: We conclude that as our participants got older there was a decrease in wheeze, no change in nocturnal
symptoms and an increase in reported asthma and allergic rhinitis. These changes in prevalence are probably related
to a decrease in smoking being counteracted by an increase in allergy, obesity and sleep related disorders.
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Background
Studies investigating time trends in asthma and respira-
tory symptoms by repeated cross sectional analyses have
shown a decrease in the prevalence of some respiratory
symptoms, a moderate increase of self-reported asthma
and a sharp increase in the prevalence of allergic rhinitis
in the last two decades [1–3]. There is, however, limited
information available on how the prevalence of respira-
tory symptoms, asthma and allergic rhinitis changes with
age. In the follow up of the European Community
Respiratory Health Survey (ECRHS II) 11,000 young
adults were followed for 10 years [4]. No large change in
respiratory symptoms was found with age, but the preva-
lence of self-reported asthma and allergic rhinitis
increased. The greater change in prevalence of allergic
rhinitis was found in the youngest age group. In the se-
cond follow-up (ECRHS III), we see a decrease in the
prevalence of wheeze while the prevalence of reported
asthma continued to increase [5]. Other longitudinal
studies of adults have shown diverging results with an
increase in wheeze and cough with age in an English
and a Canadian study [6, 7] and a decrease in the preva-
lence of wheeze in a German study [8].
* Correspondence: christer.janson@medsci.uu.se
1Department of Medical Sciences, Respiratory, Allergy and Sleep Medicine,
Uppsala University, Uppsala, Sweden
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Janson et al. BMC Pulmonary Medicine  (2018) 18:152 
https://doi.org/10.1186/s12890-018-0690-9
Subsequent analyses of data from ECRHS II has shown
an increase in obesity [9] and a sharp decrease in smo-
king [10]. Obesity was a strong risk factor for onset of
respiratory symptoms in the Respiratory Health In
Northern Europe study (RHINE) which is a 10 year
follow-up of participants in the ECRHS from the Nordic
countries [11]. It is possible that lack of change in the
prevalence of respiratory symptoms with age in the
ECRHS II [4], was related to the decrease in smoking
and increase in obesity counteracting each other. In the
RHINE study we also found that onset of respiratory
symptoms and self-reported asthma was related to sleep
related variables such as snoring and nocturnal gastro-
esophageal reflux (nGER) [11].
In 2010–2012 we conducted a second follow-up of the
RHINE population (RHINE III) [12]. This follow-up also
included information on body mass index (BMI), smo-
king, snoring and nGER. It is therefore now possible to
investigate change in respiratory health by age and fac-
tors related to this change over a 20 year period. The
aim of this investigation was to study change in the
prevalence of respiratory symptoms and its association
to year of birth, smoking, obesity, snoring and nGER.
Methods
ECRHS stage I took place in 1990–1994. In stage I of
the ECRHS, males and females aged 20–44 years were
randomly selected from the population register in the
participating centres [13]. A postal questionnaire was
sent to 3000–4000 subjects at each centre. From those
who responded, a random sample was selected to
undergo a more detailed clinical examination (stage 2).
In addition a “symptomatic sample”, reporting symp-
toms of waking with shortness of breath, asthma attacks
or using asthma medication in stage 1 were also studied.
The clinical examination included a structured interview
where the subjects were asked about symptoms, respira-
tory disorders, smoking and other types of exposure
[13]. The examination also included allergy testing,
spirometry and measuring height and weight. In some
centres an additional questionnaire collecting data on
sleep disturbances was used [14].
RHINE II is a follow-up study of participants from
ECRHS stage 1 from seven Northern European centres:
Reykjavik (Iceland); Bergen (Norway); Aarhus (Denmark);
Gothenburg, Uppsala, Umea (Sweden); and Tartu (Estonia)
[11]. RHINE II consisted of a postal questionnaire sent in
1999–2001. In 2010–2012 a second follow-up by postal
questionnaire was performed in the same centres (RHINE
III) [12, 15]. The questionnaire was once again sent out to
all participants of ECRHS stage 1. A summary of the num-
ber of participant and the data collected is presented in
Table 1.
Informed consent was obtained from each participant
and the study was approved by regional committees of
medical research ethics in each country.
Respiratory health
In all three surveys identical yes/no-questions were posed
about presence of respiratory symptoms at any time in the
last 12 months: wheezing, nocturnal chest tightness, noc-
turnal shortness of breath and nocturnal cough. Subjects
were considered to have asthma if they reported that they
currently were using medication against asthma or have
had an attack of asthma with the last 12 months [16].
Allergic rhinitis was defined as a positive answer to the
question “Do you have any nasal allergies including aller-
gic rhinitis?”. In some of the analyses nocturnal chest
tightness and nocturnal shortness of breath were com-
bined and labeled nocturnal dyspnea [11].
Year of birth
The participants were divided into three birth cohorts:
1944–1955, 1956–1965 and 1966–1975.
Life style factors
Smoking
Questions on smoking were not included in the first
survey in all centres. The second and third survey did,
however, include questions on ex- and current smoking as
well as age of starting and stopping to smoke. This infor-
mation was used to estimate whether or not a participant
was a smoker at the first survey or not. The question:
“Are you a smoker?” was used to define current smokers
in the second and third survey.
Body mass index
Body mass index (BMI) was calculated for each subject
as weight in kilograms divided by the squared height in
meters (kg/m2). Subjects with BMI ≥30 were classified
as being obese. Information on height and weight was
only collected from one centre in the first postal survey
(Bergen). In the other centres data on height and weight
collected on the subsample that underwent the clinical
investigation (stage 2) was used for the first time period.
In the second and third survey information on height
and weight were collected from questionnaires in the
same way in all centres.
Sleep related variables
The postal questionnaire in survey two and three con-
tained several multiple-choice questions in which the
subjects were asked to estimate the frequency of various
sleep related symptoms on a 5-points scale: never; less
than once a week; one to two nights a week; three to five
nights a week and almost every night [11]. For the first
survey similar information was only available from the
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subsample that underwent the clinical examination in
three of the centres: Reykjavik, Gothenburg and
Uppsala.
The question asked regarding nocturnal gastroesopha-
geal reflux was: “Do you have heartburn or belching
when you have gone to bed?” Subjects reporting these
symptoms 1 to 2 nights per week or more, are in this
study referred to as reporting nGER [11]. The question
asked regarding snoring was: “Do you snore loudly and
disturbingly?” Subjects reporting such snoring 3 to 5
times per week or more are referred to as reporting
habitual snoring [17].
Statistics
Absolute net change in symptom and disease status
between the surveys was estimated using population av-
eraged, generalised estimating equations for a binomial
outcome with identity link, with participants identified
as the clustering factor and the number of the survey as
an independent variable. Results were expressed as net
between the surveys. The Wald test was used to examine
differences in change of prevalence by birth cohort.
The influence of year of birth, life style (smoking and
BMI)and sleep related variables (snoring and nGER) on
respiratory health was analysed using mixed effects
logistic regression in order to take into account that
number of times information on risk factors was avai-
lable varied between the participants.
Estimates of the influence of birth year on allergic
rhinitis by centre were examined for heterogeneity and
combined using random effects meta-analysis.
Results
The prevalence of respiratory symptoms, asthma and aller-
gic rhinitis for those 11,269 subjects (6085 women and
5184 men, mean age (±SD) in first survey 32.2 ± 7.1 years)
that participated in all three studies is presented in Table 2.
There was a clear decrease in the prevalence of wheeze and
an increase in the prevalence of asthma and allergic rhinitis,
whereas the prevalence of nocturnal respiratory symptoms
was relatively unchanged. Change in the prevalence of
wheeze, asthma and allergic rhinitis by centre is presented
in fig. 1. Overall the trends were the same in all centres ex-
cept for wheeze where the prevalence did not decrease in
two of the seven centres (Reykjavik and Tartu). There was a
large decrease in the prevalence of smoking while an in-
crease in obesity and snoring was found when comparing
the second and third survey where data was available for a
larger proportion of the population (Table 2).
The prevalence of symptoms, asthma and rhinitis in
the three surveys relation to year of birth is presented in
figs. 2 and 3. The youngest group (born 1966–1975) had
the highest decrease in wheeze and nocturnal dyspnea,
the lowest increase in asthma and the highest increase
in allergic rhinitis.





1990–1994 21,595 14,780 6604 1867
1999–2001 16,049 15,930 15,930 15,762
2010–2012 13,093 12,738 12,930 12,811
≥ 2 surveys 17,711 13,117 12,504 11,338
All three surveys 11,269 10,858 3669 1143
Table 2 Prevalence of symptoms, disorders and lifestyle and sleep related variables for subjects who participated in all three surveys
(%, n = 11,269)
Prevalence % Change in prevalence % (95% CI)
1990–94 1999–2001 2010–2012 1990–2012 p-value
Wheeze 20.4 19.5 18.6 −2.2 (−3.0, −1.5) < 0.0001
Nocturnal chest tightness 11.1 11.3 10.3 −0.6 (−1.2, 0.1) 0.08
Nocturnal breathlessness 4.7 4.6 5.3 0.4 (−0.1, 0.8) 0.10
Nocturnal dyspnea 11.1 11.3 10.6 −0.7 (−1.2, − 0.01) 0.02
Nocturnal cough 26.6 28.2 26.9 0.2 (−0.6, 1.1) 0.55
Asthma attacks 2.8 3.3 3.5 0.9 (0.5, 1.2) < 0.0001
Asthma medication 3.6 5.5 7.6 4.1 (3.7, 4.5) < 0.0001
Asthma 4.5 6.4 8.3 4.0 (3.5, 4.5) < 0.0001
Allergic rhinitis 19.7 23.1 24.7 5.1 (4.5, 5.8) < 0.0001
Smoking 37.7 25.7 16.4 −19.6 (−20.2, −18,9) < 0.0001
Obesity (BMI > 30 kg/m2) 7.9 14.9 6.9.5 (6.4, 7.5) < 0.0001
Snoring 17.8 24.2 6.3 (5.6, 7.2) < 0.0001
Gastroesophageal reflux 7.0 7.3 0.2 (−0.4, 0.6) 0.57
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Snoring and nGER were independently related to all re-
spiratory symptoms, asthma and allergic rhinitis (Table 3).
BMI was associated with all symptoms and asthma but not
to allergic rhinitis. Smoking was related to a higher risk of
all symptoms but not asthma and allergic rhinitis. Women
had a much higher risk than men of nocturnal cough but
also of all other symptoms and disorders except wheeze.
The risk of allergic rhinitis was higher in those born
1966 or later than in those born before 1956 (Table 3).
This association was also studied by centre (Fig. 4). A
strong association between belonging to the younger age
group and allergic rhinitis was seen in all centres except
Tartu and a borderline centre heterogeneity was found
for this association (p = 0.07).
Fig. 1 Prevalence of symptoms for subjects who participated in all three surveys (%) divided by centre
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Discussion
The main result of this longitudinal study is that
wheeze decrease, nocturnal respiratory symptoms
remain unchanged and asthma and allergic rhinitis in-
creases with age. The increase in allergic rhinitis was
particularly strong in participants born after 1965 ex-
cept in Estonia. Part of these changes in symptoms
and disorders may be related to changes in life style
(smoking, diet and exercise) and sleep related factors
with a large decrease in smoking but an increase in
obesity and snoring with age [9].
Our finding of a decrease in wheeze is in accordance
with the results of analyses of repeated cross sectional
studies in Northern Europe [1, 2]. An increase in
self-reported asthma was found in the 10 and 20-year
follow up of the ECRHS [4](ref ) and in one Swedish
repeated cross sectional studies [1], while an increase in
allergic rhinitis has been found in a large number of
studies [1–3, 18].
The increase in allergic rhinitis was largest in the
youngest birth cohort – those born between 1966 and
1975. Analyses of risk factors also showed that belonging
Fig. 2 The prevalence of respiratory symptoms in relation to mean age at the three surveys for participants born 1945–1955 (blue), 1956–1965
(red) and 1966–1975 (green), respectively
Fig. 3 The prevalence of self-reported asthma and allergic rhinitis in relation to mean age at the three surveys for participants born 1945–1955
(blue), 1956–1965 (red) and 1966–1975 (green), respectively
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to the youngest birth cohort increased the likelihood of
having allergic rhinitis more than two fold. This risk as-
sociation was found in all centres except in Tartu in
Estonia. This result fits well with data from the ECRHS
showing a lower prevalence of atopy in the eastern part
of Germany [19] and a corresponding difference between
Estonia and Sweden [20]. In both these studies diffe-
rence in atopy was larger in the younger than the older
birth cohorts. Corresponding geographical differences
have also been reported from a number of studies on
children [21, 22]. The lack of age association with aller-
gic rhinitis in Tartu is probably related to the fact that
Estonia during the cold war period underwent less
environmental changes than those that occurred in the
Scandinavian countries.
Smoking and obesity were as expected associated with
respiratory symptom [11, 23–26]. Obesity was also asso-
ciated with self-reported asthma whereas this was not
the case for smoking. During the follow up there was a
large decrease in smoking and an increase in obesity.
Other cohort studies. Have also found a clear positive
association between incidence of wheeze and smoking
[6, 7, 27]. We have previously found that smoking cessa-
tion and weight gain counteract each other when it
comes to the effect of change in lung function [9]. It is
therefore probably that the relative stability found in the
Table 3 Year of birth, gender, life style and sleep related variables in association with respiratory symptoms and disorder (adjusteda
odds ratio (95% CI))
Wheeze Nocturnal dyspnea Nocturnal cough Asthma Allergic rhinitis
Born 1945–1955 1 1 1 1 1
1956–1965 1.04 (0.92–1.18) 0.93 (0.82–1.05) 1.03 (0.93–1.14) 1.03 (0.84–1.27) 1.62 (1.32–1.99)
1966–1975 1.14 (0.99–1.33) 0.95 (0.81–1.10) 1.11 (0.99–1.25) 1.05 (0.82–1.34) 2.36 (1.85–3.01)
Women 1.09 (0.97–1.22) 1.26 (1.13–1.41) 2.35 (2.14–2.57) 1.66 (1.38–2.01) 1.58 (1.32–1.89)
Smokers 5.65 (5.00–6.38) 1.68 (1.49–1.89) 2.04 (1.86–2.25) 0.98 (0.81–1.18) 0.60 (0.51–0.72)
Obesity 2.97 (2.55–3.45) 1.69 (1.45–1.96) 1.78 (1.57–2.02) 2.05 (1.62–2.60) 0.86 (0.68–1.09)
Snoring 1.85 (1.64–2.09) 1.71 (1.51–1.94) 1.56 (1.41–1.72) 1.61 (1.33–1.95) 1.42 (1.19–1.70)
Gastroesophageal reflux 2.85 (2.41–3.37) 3.67 (3.13–4.31) 2.50 (2.17–2.88) 2.78 (2.17–3.57) 1.73 (1.34–2.23)
aadjusted for centre and all the variables in the table
Fig. 4 Odds ratio for allergic rhinitis in those born after 1965 compared to those born before 1956 by study centre. The odds ratio is adjusted for
sex, smoking, body mass index, gastro-esophageal reflux and centre. The area of each square is proportional to the reciprocal of the variance of
the estimate for the country. The combined random effects estimate is shown by the dashed line, the diamond having the width of its 95%
confidence interval
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prevalence of all respiratory symptoms except wheeze is
related to the beneficial effect of less smoking being
balanced by the negative effect of increasing obesity.
Snoring was as in previous studies found to be associ-
ated with wheeze and nocturnal symptoms [11, 28]. In
accordance to previous studies we also found an asso-
ciation between nGER and respiratory symptoms and
disorders [11, 29–31]. Snoring became more prevalent
as our population got older. This may partly be related
to weight gain and may together with increasing obesity
explain why there was no change in nocturnal respira-
tory symptoms despite a large decrease in smoking.
The strengths of this study are the large population
size and the long follow-up time. The questions used are
standardized and have been used in a large number of
previous studies [32, 33]. The response rate is acceptable
given the long follow-up time and the long term re-
sponders were fairly similar to non-responders in term
of symptomatology [12]. A draw-back is that our results
are only based on self-reported data and that there was a
variation in the amount of data that was available at the
different surveys.
Conclusion
We conclude that as our participants got older there was
a decrease in wheeze, no change in nocturnal symptoms
and an increase in reported asthma and allergic rhinitis.
The increase in allergic rhinitis was particularly strong in
younger adults except in Estonia. These changes in preva-
lence are probably related to a decrease in smoking being
counteracted by an increase in allergy, obesity and sleep
related disorders. Measures targeting obesity and sleep
disordered breathing maybe important in order to reduce
the burden of respiratory disorders in the society.
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